Table 6.
Baseline clinical features of eyes.
| Baseline Status | Total (N = 74) | Stickler Type 1 (N = 60) | Stickler Type 2 (N = 14) | |
|---|---|---|---|---|
| Mean BCVA (logMAR) |
0.40 ± 0.56 (n = 60) | 0.39 ± 0.57 (n = 48) | 0.45 ± 0.57 (n = 12) | |
| Mean (range) Refractive error (D) |
−8.23 ± 5.55 (−23 ± 0.125, n = 66) |
−8.12 ± 5.49 (−23 ± 0, n = 52) |
−8.62 ± 5.98 (−20 ± 0.125, n = 14) |
|
| Mean (range) Axial length (mm) |
27.59 ± 2.14 (23.74–31.64, n = 32) |
27.39 ± 2.17 (23.74–31.64, n = 26) |
28.43 ± 1.93 (26.39–31.26, n = 6) |
|
| Mean (range) age at the time of axial length measurement (year) | 24.75 ± 17.38 (4–56, n = 32) |
23.23 ± 17.48 (4–56, n = 26) |
31.33 ± 16.74 (10–45, n = 6) |
|
| Lens | Phakia, with cataract (%) | 12 (16.2) | 6 (10.0) | 6 (42.9) |
| Phakia, without cataract (%) | 46 (62.2) | 42 (70.0) | 4 (28.6) | |
| Pseudophakia (%) | 11 (14.9) | 6 (10.0) | 5 (35.7) | |
| Aphakia (%) | 2 (2.7) | 2 (3.3) | 0 (0) | |
| Anophthalmos (%) | 2 (2.7) | 2 (3.3) | 0 (0) | |
| Vitreous | Membranous vitreous (%) | 35 (47.3) | 31 (51.7) | 4 (28.6) |
| Beaded vitreous (%) | 5 (6.8) | 5 (8.3) | 0 (0) | |
| Initial PVD (%) | 17 (23.0) | 13 (21.7) | 4 (28.6) | |
| N/A (%) | 10 (13.5) | 9 (15.0) | 1 (7.1) | |
| Retina | Paravascular pigmented atrophic lesion (%) | 26 (35.1) | 21 (35.0) | 4 (28.6) |
| Lattice degeneration (%) | 54 (73.0) | 45 (75.0) | 9 (64.3) | |
| Foveal hypoplasia (%) | 21 (28.4) | 16 (26.7) | 5 (35.7) | |
| N/A (%) | 3 (4.1) | 3 (5.0) | 0 (0) | |